Human Regulatory Gamma Delta T Lymphocytes as Novel Autoimmunity-Protective Cells: Lessons from Alopecia Areata

    November 2024
    Amos Gilhar, Aviad Keren, Nyra Goldstein, Marta Bertolini, Riad Kassem, Assaf Zeltzer, Nataša Štrbo, Ralf Paus
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that γδTregs can prevent and treat alopecia areata in a mouse model with human scalp transplants, suggesting potential for cell-based therapies in autoimmune diseases like alopecia.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This study investigates the role of human regulatory γδT cells (γδTregs) in alopecia areata (AA), a common autoimmune hair loss disorder. The research found that γδTregs are more prevalent in lesional AA skin compared to non-lesional or healthy skin. In experiments using human scalp skin xenotransplants on mice, γδTregs, pre-activated with IL-2, IL-15, and zoledronate, were able to prevent AA lesion development and promote hair regrowth by reducing lymphocytic infiltration and restoring hair follicle immune privilege. Additionally, γδTregs co-cultured with stressed human scalp hair follicles mitigated immune privilege collapse and enhanced keratinocyte proliferation, primarily through IL-10 and TGF-β1 secretion. These findings suggest that γδTregs could be a novel therapeutic target for CD8+ T cell-dependent autoimmune diseases like AA.
    Discuss this study in the Community →

    Research cited in this study

    39 / 39 results